Covista's Chamberlain nursing-school unit is showing early signs of a turnaround, with back-to-back quarters of double-digit application growth. In a Friday note, Truist Securities highlighted the trend and suggested a new corporate partnership could be on the horizon by the end of 2026, potentially boosting enrollment and revenue.
What's Driving the Optimism?
Truist, an investment bank, pointed to recent leadership changes at Chamberlain that could help convert rising interest into actual enrollment growth. The firm expects mid-to-high single-digit enrollment gains, a meaningful improvement for a unit that has faced headwinds in recent years. The bank also noted that Chamberlain's existing partnership with SSM Health, a large health system, could serve as a template for similar deals with other employers or hospitals. Such tie-ups would provide a steadier pipeline of students, as healthcare organizations often subsidize tuition in exchange for commitments to work after graduation.
If a new partnership materializes, Truist believes Covista's results could come in better than Wall Street currently expects. That kind of outperformance can influence how investors value the stock, especially in a sector where growth stories are closely watched.
The Catch: Rising Costs
But the bank also flagged a potential downside. Expanding campuses to accommodate more students is expensive. Truist estimates Covista's fiscal 2027 capital spending could rise to $110 million, above the consensus estimate of $101 million. That extra spending could weigh on free cash flow—the cash left after operating costs and investments—and pressure returns on invested capital in the near term.
For context, capital spending refers to money a company puts into buildings, equipment, or other long-term assets. While necessary for growth, it can temporarily reduce the cash available to shareholders or for debt repayment. Investors often watch free cash flow closely as a measure of financial health.
What It Means for Investors
Application and enrollment growth can brighten Covista's revenue outlook, but markets usually want to see that growth translate into cash. Higher capital spending can delay that payoff, meaning the stock's next move may depend on whether fiscal 2027 cash conversion holds up while the campus expansion ramps up. In other words, the growth headlines alone may not be enough—investors will also be looking at the payback math from that spending wave.
This dynamic is not unique to Covista. Many companies in similar positions face a trade-off between investing for future growth and delivering near-term returns. For everyday investors, it's a reminder to look beyond top-line metrics like application growth and consider the full picture of costs and cash flow.
Broader Context
The nursing education market has been under pressure in recent years, with some for-profit schools facing regulatory scrutiny and enrollment declines. Chamberlain's rebound could signal a broader stabilization, especially as demand for healthcare workers remains high. The aging population and ongoing healthcare staffing shortages continue to drive interest in nursing programs, which bodes well for schools that can attract and retain students.
However, the sector also faces challenges, including rising operational costs and competition from community colleges and online programs. Covista's ability to secure corporate partnerships could be a key differentiator, providing a more predictable revenue stream and reducing reliance on individual student enrollments.
Looking Ahead
Investors will likely watch for updates on Chamberlain's enrollment numbers and any announcements of new partnerships. Truist's $110 million capital spending forecast for fiscal 2027 will also be a focus, as it could signal how aggressively Covista is investing in growth. If the company can balance expansion with cash flow discipline, the stock could see a re-rating. But if spending outpaces returns, the payoff may take longer than expected.
For now, the early signs are encouraging, but the road ahead requires careful execution. As always, investors should consider their own risk tolerance and investment goals when evaluating opportunities in the education sector.
